May 18, 2020 / 1:15 PM / 10 days ago

BRIEF-Heron Begins Study Of Htx-034 For Treatment Of Postoperative Pain

May 18 (Reuters) - Heron Therapeutics Inc:

* HERON THERAPEUTICS ANNOUNCES INITIATION OF PHASE 1B/2 CLINICAL STUDY OF HTX-034 FOR THE TREATMENT OF POSTOPERATIVE PAIN Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below